Integra LifeSciences Holdings (IART)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	28,412	28,832	63,575	79,108	111,526	143,319	181,775	229,138	238,920	229,303	220,693	212,680	197,230	191,652	192,755	154,981	151,370	134,805	56,676	88,555
Revenue (ttm)	US$ in thousands	1,596,615	1,533,335	1,521,985	1,473,066	1,486,381	1,488,778	1,493,656	1,509,844	1,505,291	1,519,581	1,519,648	1,510,233	1,535,982	1,529,270	1,504,267	1,371,086	1,317,264	1,323,744	1,339,441	1,466,719
Operating profit margin		1.78%	1.88%	4.18%	5.37%	7.50%	9.63%	12.17%	15.18%	15.87%	15.09%	14.52%	14.08%	12.84%	12.53%	12.81%	11.30%	11.49%	10.18%	4.23%	6.04%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $28,412K ÷ $1,596,615K
= 1.78%

Integra LifeSciences Holdings has shown varying levels of operating profit margin over the analyzed period from March 31, 2020, to December 31, 2024. The operating profit margin fluctuated between a low of 1.78% in December 31, 2024, and a high of 15.87% in December 31, 2022.

The trend in the operating profit margin shows initial improvements from March 2020 to December 2022, indicating increasing profitability. However, in the latter part of the reviewed period, there was a noticeable decline in the operating profit margin, dropping to 1.78% by the end of December 2024. This downward trend could be indicative of potential challenges or inefficiencies impacting the company's operating performance.

It would be essential for Integra LifeSciences Holdings to conduct a thorough analysis to identify the factors contributing to the fluctuations in operating profit margin and implement appropriate strategies to improve operational efficiency and profitability in the future.